However, SMO mutants have shown to be significantly associated with shorter survival in malignant pleural mesothelioma [225] and olfactory groove meningioma [226] patients, suggesting that SMO mutational features defining a molecular subgroup in cancers are better indicators of poor prognosis than wild-type SMO. The gene discussed is SMO; the disease is cancer.